Globus Medical (GMED) Tops Q4 EPS by 7c, FY Guidance Falls Short of Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Globus Medical Reports Fourth Quarter and Full Year 2020 Results
February 17, 2021 4:15 PM ESTAUDUBON, Pa., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2020.
Fourth Quarter 2020:
Worldwide net sales were $233.4 million, an increase of 10.3% as compared to the fourth quarter of 2019GAAP net income for the quarter was $53.0 million, or 22.7% of net salesGAAP diluted earnings per share (EPS) was $0.52 and non-GAAP diluted... More